Navigation Links
Mesa Labs Reports Higher Quarterly Sales and Earnings
Date:11/10/2008

Average Shares (Basic) 3,179,000 3,169,000 3,175,000 3,170,000

Average Shares (Diluted) 3,258,000 3,288,000 3,259,000 3,289,000

BALANCE SHEETS (Unaudited)

Sept. 30 March 31

2008 2008

Cash and Short-term

Investments $6,728,000 $5,770,000

Other Current Assets 9,363,000 8,641,000

Total Current Assets 16,091,000 14,411,000

Property and Equipment 3,477,000 3,488,000

Other Assets 7,577,000 7,634,000

Total Assets $27,145,000 $25,533,000

Liabilities $1,508,000 $1,794,000

Stockholders' Equity 25,637,000 23,739,000

Total Liabilities and

Equity $27,145,000 $25,533,000


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... recruited annually to participate in clinical tri...rotection (AHRP), and most will be compensated for...s view payments to volunteers as compensation for ...al risks related to participating in the experimen...very different view of clinical trial compensation...
(Date:12/4/2009)...sm is a phenomenon that was started by people that... of dental work in the US, Canada, and other count..., people have found that Mexican Dental Vacation i... , (PRWEB) December 4, 200..., Mexican Dental Vacation is seeing their best yea...
(Date:12/4/2009)...consumption leads to success, study finds , ...ed exercise, reduced soda consumption and self-wei...strategies for adolescents, a new study shows. ,... weight-control strategies and lifestyle habits. S... not. The responses were grouped into four categor...
(Date:12/4/2009)... -- Substantial progress has been made over the la...to diagnose and treat epilepsy and its complicatio...not reached most of the 50 million people around t...on people in the United States who have the disord...president of the American Epilepsy Society (AES), ...
(Date:12/4/2009)...-risk patient groups , , FRIDAY, Dec. 4 ...ularly Ewing sarcomas and central nervous system t...earchers have found. , The study authors analyz...t common pediatric cancers who were enrolled in th...chers found that the overall cancer recurrence rat...
Breaking Medicine News(10 mins):Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4
...ng against older brothers and sisters can be tough... new research from a biologist at the University o... comes to some birds, you should reserve any under... counter to common wisdom, which holds that baby b...
...ilable in French . , Quebec City, March 12, 200...entist Marc-Andr Sirard has identified genetic mar...t chance of leading to successful pregnancy after ...s. The details of the method developed by the rese...
...solutions from presidential candidates, Congress, ...Independent Business (NFIB), the nation,s leading ...unch of Solutions Start Here, an,aggressive health...etter today to the presidential candidates,challen...
..., led by Professor Jon Dobson, of Keele University...ime, raised levels of magnetic iron oxides in the ...(AD). , Their research has also shown that this ...body handles and stores iron. , Though the resul...
...ht Watchers program and obesity training, state,s,...ng with the American Lung, Association to provid... certified in conducting Breathe Well, Live ...th Plan of West Virginia, Inc. (UniCare) continues...
... Keystone and other initiatives are featured, DET...rofessionals provide an inside look at how groundb...nd Blue Cross Blue Shield of Michigan are,saving l...l, positive impact created,by hospitals, physician...
Other Medicine News:Health News:Early bird doesn't always get worm, UNC researcher finds 2Health News:Researchers develop a method to select eggs with the best chance of leading to successful pregnancy 2Health News:National Federation of Independent Business Launches Aggressive Campaign to Drive Healthcare Reform: Solutions Start Here 2Health News:National Federation of Independent Business Launches Aggressive Campaign to Drive Healthcare Reform: Solutions Start Here 3Health News:National Federation of Independent Business Launches Aggressive Campaign to Drive Healthcare Reform: Solutions Start Here 4Health News:Increased level of magnetic iron oxides found in Alzheimer's disease 2Health News:UniCare of West Virginia Providing Assistance for Asthma Education Training 2Health News:UniCare of West Virginia Providing Assistance for Asthma Education Training 3Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 2Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 3Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 4
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstCa..., a leading global specialty pharmaceutical compan...oratories, Inc.-Florida, filed an Abbreviated New ...g Administration seeking approval to market its 8m...atent owned by Takeda Pharmaceutical Company Limit...
(Date:12/4/2009)..., WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCal...hat the US Food and Drug Administration (FDA) has ...fumarate) Extended Release Tablets as adjunctive (...h Major Depressive Disorder (MDD). SEROQUEL XR is ...DA to treat both major depressive disorder as adju...
(Date:12/3/2009)... , ALISO VIEJO, Calif. and STATE COLLEGE, Pa., ...tics today announced the signing of an agreement t...s using SoftGenetics, NextGENe software for next-g... ,, (Logo: http://www.newscom.com/cgi-bin/pr...hD, Ambry,s CSO said, "Our team at Ambry has been ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3American Red Cross Charged With Bio Hazardous Waste Dumping 52159 1Insulet Corporation to Report Second Quarter 2009 Financial Results on Tuesday August 4 2009 52157 1Insulet Corporation to Report Second Quarter 2009 Financial Results on Tuesday August 4 2009 52157 2MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 1MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 2MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 3MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 4MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 5
... Eli Lilly and Co (NYSE:,LLY) and Boehringer Ingel...nal Products for Human Use (CHMP) of the European ...ion supporting the approval of Cymbalta(R),(duloxe...ed Anxiety,Disorder (GAD)., The positive opinion ...,-- four double-blind placebo-controlled studies a...
...on Data from Placebo-Controlled Phase III Trial; ...omized Study, WOODCLIFF LAKE, N.J., June 26 Eisa...t the U.S. Food and Drug Administration,(FDA) has ...ics license,application (sBLA) for ONTAK(R). The s...ation into full approval. It is based on a placebo...
Other Medicine Technology:European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 2European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 3European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 4European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 5European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 6FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 2FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 3FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 4FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL) 5
Recipient Needle, 1.5 mm, Spare part for ATA100
Donor Needle, 1.5 mm, Spare part for ATA100
Recipient Collet, 0.6 mm, Spare part for ATA100
Donor Needle, 0.6 mm, Spare part for ATA100
Medicine Products: